Page last updated: 2024-10-24

chloroquine and Cancer of Pituitary

chloroquine has been researched along with Cancer of Pituitary in 6 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"Chloroquine (CQ) is an old drug widely used to treat malaria."1.46Pituitary Tumor Suppression by Combination of Cabergoline and Chloroquine. ( Cao, L; Guo, YH; Leng, ZG; Lin, SJ; Shang, HB; Wu, ZB; Wu, ZR; Zhang, X; Zhang, Y; Zhao, WG, 2017)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, SJ1
Wu, ZR1
Cao, L1
Zhang, Y1
Leng, ZG1
Guo, YH1
Shang, HB1
Zhao, WG1
Zhang, X1
Wu, ZB1
Halpern, J1
Hinkle, PM1
Westendorf, JM1
Schonbrunn, A2
Steinsapir, J1
Harney, J1
Larsen, PR1
Stoller, TJ1
Shields, D1
Presky, DH1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effect of Combined Treatment of Cabergoline With Hydroxychloroquine/Chloroquine for Resistant Prolactinomas[NCT03400865]30 participants (Anticipated)Interventional2018-10-25Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

6 other studies available for chloroquine and Cancer of Pituitary

ArticleYear
Pituitary Tumor Suppression by Combination of Cabergoline and Chloroquine.
    The Journal of clinical endocrinology and metabolism, 2017, 10-01, Volume: 102, Issue:10

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cabergoline; Cell Death; Cells, Cultured; C

2017
Evidence for an active step in thyroid hormone transport to nuclei: drug inhibition of L-125I-triiodothyronine binding to nuclear receptors in rat pituitary tumor cells.
    Endocrinology, 1982, Volume: 110, Issue:3

    Topics: Animals; Antineoplastic Agents; Biological Transport, Active; Cadaverine; Cell Line; Cell Nucleus; C

1982
Characterization of bombesin receptors in a rat pituitary cell line.
    The Journal of biological chemistry, 1983, Jun-25, Volume: 258, Issue:12

    Topics: Animals; Binding, Competitive; Bombesin; Cell Line; Chloroquine; Kinetics; Neoplasms, Experimental;

1983
Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes.
    The Journal of clinical investigation, 1998, Dec-01, Volume: 102, Issue:11

    Topics: Adenosine Triphosphate; Animals; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chloroquine; Cycloheximi

1998
The propeptide of preprosomatostatin mediates intracellular transport and secretion of alpha-globin from mammalian cells.
    The Journal of cell biology, 1989, Volume: 108, Issue:5

    Topics: Animals; beta-Lactamases; Cell Line; Chloroquine; Globins; Kinetics; Pituitary Neoplasms; Protein Pr

1989
Receptor-bound somatostatin and epidermal growth factor are processed differently in GH4C1 rat pituitary cells.
    The Journal of cell biology, 1986, Volume: 102, Issue:3

    Topics: Ammonium Chloride; Animals; Cell Compartmentation; Cell Line; Cell Membrane; Chloroquine; Cytosol; E

1986